RNA-TEC Overview

  • Founded
  • 2000

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

RNA-TEC General Information


Producer of synthetic DNA and RNA intended to identify the carriers of genetic information. The company's technology unmodified as well as with base and/or sugar modifications - and non-radioactive isotopically labeled (13C and 15N) nucleic acid products, enabling researches in the large research institutes and pharmaceutical companies to deal with RNA specific research.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • Leuven
  • Belgium

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RNA-TEC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 18-Sep-2006 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view RNA-TEC’s complete valuation and funding history, request access »

RNA-TEC Patents

RNA-TEC Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-6900301-A Labeled nucleosides and method for their preparation Inactive 10-May-2000 00000000000

RNA-TEC Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
KU Leuven Research & Development Venture Capital Minority 000 0000 000000 0
To view RNA-TEC’s complete investors history, request access »